CARA

Name

CARA

Legal name

CARA Technologies

Website

https://carasystems.co

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

AI Clinical Decision Support for Neurovascular Care

NAICS

Software Publishers (5132), Other Computer Related Services (541519)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Diagnostic & Triage Decision Support (HLACAGAA)

akta.pro secondary industries

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Medical Imaging AI (HDAAAEAH)

Keywords

• AI clinical decision support
• Neurovascular diagnostics
• Aneurysm risk prediction
• Medical imaging AI
• Healthcare SaaS

Headquarters

HQ city

Brooklyn

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Subscription Plans: Flexible subscription plans for healthcare institutions of all sizes, offering recurring revenue with tiered access to AneuView™️ features and capabilities.
2. Pay-per-use: Flexible pay-per-use option allowing hospitals to pay only for the cases analyzed, offering consumption-based billing for institutions preferring variable cost structures.
3. One-time Implementation: One-time fixed implementation fee for initial deployment, customization, and training services.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

CARA sells AneuView™️, a cloud-native SaaS clinical decision intelligence platform that uses proprietary AI to fuse medical imaging, hemodynamic, and clinical data into interpretable brain aneurysm rupture risk predictions and neurovascular triage scores for neurospecialists at the point of care. The offering is delivered to hospitals through flexible subscription plans, pay-per-use case-based billing, and one-time implementation/onboarding fees, and includes Epic-ready EHR integration and longitudinal patient monitoring.

Product overview

CARA offers a single unified AI-powered product called AneuView™️ — a clinical decision intelligence engine for precision neurovascular care. The platform serves as an AI-Copilot for Neurospecialists, combining multimodal intelligence (imaging + hemodynamics + clinical data) with workflow automation capabilities. Key features include AI-powered risk scoring, longitudinal monitoring of aneurysm changes over time, seamless EHR integration (Epic-ready), and cloud-native SaaS delivery. The system is designed for acute clinical settings, enabling evidence-based, timely interventions for aneurysm and stroke cases.

Differentiator

Problem solved

Functional benefit

Brands

• AneuView™️: AI-Copilot for neurospecialists providing clinical decision intelligence for precision neurovascular care, including risk scoring, interpretable rupture prediction, multimodal intelligence, workflow automation, longitudinal monitoring, proven cost savings, seamless EHR integration, and cloud-native SaaS delivery.

Products and services

• AneuView™️ Cloud-native SaaS clinical decision intelligence platform that combines AI-powered risk scoring, multimodal data fusion (imaging + hemodynamics + clinical data), workflow automation, longitudinal aneurysm monitoring, and Epic-ready EHR integration to deliver interpretable brain aneurysm rupture risk predictions and neurovascular triage for neurospecialists at the point of care in academic medical centers and stroke hospitals.

Quantifiable outcome

• 50-70% reduction in manual imaging workload
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature7 records

Partnerships

Three partnerships are on record, tiered core.

• NYU Langone HealthcoreStrategic or Co-development PartnerRobust clinical collaboration with NYU Langone for validation studies and pilot programs. Dr. Albert S. Favate, Division Chief of Vascular Neurology, serves as clinical collaborator and provides testimonial on CARA's platform transforming risk evaluation and triage workflows.
• Bellevue HospitalcoreStrategic or Co-development PartnerClinical collaboration for validation studies and early pilot programs in neurovascular care, contributing to the development and clinical validation of CARA's AI-driven decision support system.
• Academic Medical Centers (Partners)coreStrategic or Co-development PartnerStrategic partnerships with leading academic medical centers and stroke hospitals. These collaborations drive validation studies and early pilot programs with top clinicians to validate and refine the AneuView™️ platform.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Viz.ai: Viz.ai is a direct competitor offering AI-powered clinical decision support and workflow coordination for neurovascular conditions, particularly stroke and aneurysm triage. Both companies target similar academic medical centers and high-volume stroke centers with similar enterprise SaaS models.
• RapidAI: RapidAI provides AI-driven neuroimaging analysis for stroke and aneurysm care, with FDA-cleared products serving similar hospital neurology and radiology workflows. Directly comparable in target customers (academic medical centers, stroke centers), use cases (cerebrovascular triage), and product category (clinical decision support AI).
• Aidoc: Aidoc provides AI-powered workflow and decision support for medical imaging, including neurovascular findings such as aneurysm detection. Comparable as a hospital-deployed AI imaging platform with enterprise SaaS distribution to academic centers.
• Brainomix: Brainomix develops AI-based imaging biomarkers for stroke and cerebrovascular disease assessment, deployed across hospital networks globally. Comparable as an AI medical imaging company targeting stroke centers with similar clinical decision support functionality.
• icometrix: icometrix develops AI-based imaging biomarkers for neurological conditions including stroke and other cerebrovascular disorders. Comparable as an AI neuro-imaging company with similar clinical evidence-driven approach and enterprise hospital distribution.

Emerging players

• Avicenna.AI: Avicenna.AI develops AI tools for medical imaging workflow triage, with FDA-cleared products covering neurovascular and other acute findings. Comparable as a focused medical imaging AI company addressing hospital triage and workflow challenges.
• Nico.lab: Nico.lab offers AI-based stroke imaging analysis tools (e.g., StrokeViewer) for emergency and neurovascular workflows. Comparable as a focused neurovascular AI company targeting similar clinical use cases in acute stroke triage.

Broad incumbents

• Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion, a broad radiology AI portfolio deployed across hospital systems, including capabilities relevant to neuroimaging workflows. Comparable as a broad incumbent with imaging AI capabilities that could expand into neurovascular triage at scale.
• GE HealthCare (Edison AI): GE HealthCare's Edison AI platform provides imaging AI and clinical decision support integrated into hospital radiology and neurology workflows. Comparable as a broad incumbent whose imaging AI ecosystem overlaps with CARA's enterprise hospital go-to-market motion.

Regional players

• Circle Cardiovascular Imaging: Circle CVI provides AI-driven cardiac and vascular MR/CT imaging analysis, including cerebral aneurysm assessment tools. Comparable as an adjacent imaging AI vendor in cardiovascular/cerebrovascular analysis with similar hospital SaaS deployment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CARA